CASE REPORTS
JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Nasolacrimal duct obstruction caused by an oncocytoma.

Rhinology 2002 September
We report the case of a woman with epiphora and purulent rhinorrhea for which she initially underwent a dacryocystorhinostomy. The unilateral rhinorrhea was persistent and one year later an oncocytoma of the lacrimal sac with extension to the nasolacrimal duct was diagnosed. Surgical excision of the tumour via a medial maxillectomy was accomplished. Long-term follow-up for 10 years was without evidence of recurrence. To our knowledge only 22 oncocytomas of the lacrimal sac but none involving the duct have so far been reported. In patients with acquired nasolacrimal duct obstruction a lacrimal sac or nasolacrimal duct tumour though rare is a possibility and should be kept in mind. The majority of these tumours are malignant and oncocytomas may undergo malignant transformation.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app